|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
130,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,187 |
| Total Buy Value |
$0 |
$0 |
$0 |
$38,963 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
368,228 |
564,339 |
737,202 |
755,716 |
| Total Sell Value |
$24,836,625 |
$34,740,648 |
$43,206,824 |
$43,751,353 |
| Total People Sold |
6 |
10 |
10 |
10 |
| Total Sell Transactions |
10 |
23 |
38 |
44 |
| End Date |
2025-09-07 |
2025-06-06 |
2024-12-06 |
2023-12-07 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Monroe Terilyn J. |
Chief People Officer |
• – – |
2025-12-01 |
4 |
S |
$105.33 |
$5,846,163 |
D/D |
(55,167) |
20,920 |
|
- |
|
| Monroe Terilyn J. |
Chief People Officer |
• – – |
2025-12-01 |
4 |
OE |
$20.14 |
$1,134,050 |
D/D |
50,000 |
76,087 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2025-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
155 |
18,591 |
|
- |
|
| Mignone Roberto |
Director |
– • – |
2025-11-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
264 |
3,431 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-11-19 |
4 |
S |
$96.25 |
$11,165 |
D/D |
(116) |
7,859 |
|
- |
|
| Hidalgo Medina Manuel |
Director |
– • – |
2025-11-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
232 |
1,047 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
7,975 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2025-11-07 |
4 |
S |
$96.25 |
$865,865 |
D/D |
(8,996) |
43,172 |
|
- |
|
| Hidalgo Medina Manuel |
Director |
– • – |
2025-11-07 |
4 |
S |
$95.17 |
$142,780 |
D/D |
(1,500) |
815 |
|
- |
|
| Hidalgo Medina Manuel |
Director |
– • – |
2025-11-07 |
4 |
OE |
$32.55 |
$32,550 |
D/D |
1,000 |
2,315 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2025-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
18,436 |
|
- |
|
| Mignone Roberto |
Director |
– • – |
2025-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2025-10-17 |
4 |
S |
$66.95 |
$1,741 |
D/D |
(26) |
18,324 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-10-17 |
4 |
S |
$66.95 |
$7,766 |
D/D |
(116) |
7,725 |
|
- |
|
| Hidalgo Medina Manuel |
Director |
– • – |
2025-10-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
232 |
1,315 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
7,841 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2025-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
69 |
18,350 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$440,116 |
D/D |
(7,025) |
44,316 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,859 |
51,341 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
D |
$62.65 |
$761,949 |
D/D |
(12,162) |
1,997,874 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,997 |
2,010,036 |
|
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
D |
$62.65 |
$761,949 |
D/D |
(12,162) |
2,137,708 |
|
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,997 |
2,149,870 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$359,611 |
D/D |
(5,740) |
57,439 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,550 |
63,179 |
|
- |
|
1052 Records found
|
|
Page 1 of 43 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
